185 related articles for article (PubMed ID: 30851139)
1. Two CFTR mutations within codon 970 differently impact on the chloride channel functionality.
Amato F; Scudieri P; Musante I; Tomati V; Caci E; Comegna M; Maietta S; Manzoni F; Di Lullo AM; De Wachter E; Vanderhelst E; Terlizzi V; Braggion C; Castaldo G; Galietta LJV
Hum Mutat; 2019 Jun; 40(6):742-748. PubMed ID: 30851139
[TBL] [Abstract][Full Text] [Related]
2. Antisense oligonucleotide-mediated correction of CFTR splicing improves chloride secretion in cystic fibrosis patient-derived bronchial epithelial cells.
Michaels WE; Bridges RJ; Hastings ML
Nucleic Acids Res; 2020 Jul; 48(13):7454-7467. PubMed ID: 32520327
[TBL] [Abstract][Full Text] [Related]
3. Multi-physiopathological consequences of the c.1392G>T CFTR mutation revealed by clinical and cellular investigations.
Farhat R; El-Seedy A; El-Moussaoui K; Pasquet MC; Adolphe C; Bieth E; Languepin J; Sermet-Gaudelus I; Kitzis A; Ladevèze V
Biochem Cell Biol; 2015 Feb; 93(1):28-37. PubMed ID: 25403292
[TBL] [Abstract][Full Text] [Related]
4. Modeling Cystic Fibrosis Using Pluripotent Stem Cell-Derived Human Pancreatic Ductal Epithelial Cells.
Simsek S; Zhou T; Robinson CL; Tsai SY; Crespo M; Amin S; Lin X; Hon J; Evans T; Chen S
Stem Cells Transl Med; 2016 May; 5(5):572-9. PubMed ID: 27034411
[TBL] [Abstract][Full Text] [Related]
5. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
[TBL] [Abstract][Full Text] [Related]
6. The HDAC inhibitor SAHA does not rescue CFTR membrane expression in Cystic Fibrosis.
Bergougnoux A; Petit A; Knabe L; Bribes E; Chiron R; De Sario A; Claustres M; Molinari N; Vachier I; Taulan-Cadars M; Bourdin A
Int J Biochem Cell Biol; 2017 Jul; 88():124-132. PubMed ID: 28478266
[TBL] [Abstract][Full Text] [Related]
7. In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study.
Sermet-Gaudelus I; Renouil M; Fajac A; Bidou L; Parbaille B; Pierrot S; Davy N; Bismuth E; Reinert P; Lenoir G; Lesure JF; Rousset JP; Edelman A
BMC Med; 2007 Mar; 5():5. PubMed ID: 17394637
[TBL] [Abstract][Full Text] [Related]
8. ORKAMBI-Mediated Rescue of Mucociliary Clearance in Cystic Fibrosis Primary Respiratory Cultures Is Enhanced by Arginine Uptake, Arginase Inhibition, and Promotion of Nitric Oxide Signaling to the Cystic Fibrosis Transmembrane Conductance Regulator Channel.
Wu YS; Jiang J; Ahmadi S; Lew A; Laselva O; Xia S; Bartlett C; Ip W; Wellhauser L; Ouyang H; Gonska T; Moraes TJ; Bear CE
Mol Pharmacol; 2019 Oct; 96(4):515-525. PubMed ID: 31427400
[TBL] [Abstract][Full Text] [Related]
9. Assessing the residual CFTR gene expression in human nasal epithelium cells bearing CFTR splicing mutations causing cystic fibrosis.
Masvidal L; Igreja S; Ramos MD; Alvarez A; de Gracia J; Ramalho A; Amaral MD; Larriba S; Casals T
Eur J Hum Genet; 2014 Jun; 22(6):784-91. PubMed ID: 24129438
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.
Kerem E
Pediatr Pulmonol; 2005 Sep; 40(3):183-96. PubMed ID: 15880796
[TBL] [Abstract][Full Text] [Related]
11. Spliceosome-mediated RNA trans-splicing with recombinant adeno-associated virus partially restores cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway epithelial cells.
Liu X; Luo M; Zhang LN; Yan Z; Zak R; Ding W; Mansfield SG; Mitchell LG; Engelhardt JF
Hum Gene Ther; 2005 Sep; 16(9):1116-23. PubMed ID: 16149910
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of cystic fibrosis transmembrane conductance regulator mutations.
Mickle JE; Cutting GR
Clin Chest Med; 1998 Sep; 19(3):443-58, v. PubMed ID: 9759548
[TBL] [Abstract][Full Text] [Related]
13. Lack of correlation between CFTR expression, CFTR Cl- currents, amiloride-sensitive Na+ conductance, and cystic fibrosis phenotype.
Beck S; Kühr J; Schütz VV; Seydewitz HH; Brandis M; Greger R; Kunzelmann K
Pediatr Pulmonol; 1999 Apr; 27(4):251-9. PubMed ID: 10230924
[TBL] [Abstract][Full Text] [Related]
14. Two cystic fibrosis transmembrane conductance regulator mutations have different effects on both pulmonary phenotype and regulation of outwardly rectified chloride currents.
Fulmer SB; Schwiebert EM; Morales MM; Guggino WB; Cutting GR
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6832-6. PubMed ID: 7542778
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of a novel CFTR mutation P67S identified in a patient with atypical cystic fibrosis.
Kraus C; Reis A; Naehrlich L; Dötsch J; Korbmacher C; Rauh R
Cell Physiol Biochem; 2007; 19(5-6):239-48. PubMed ID: 17495464
[TBL] [Abstract][Full Text] [Related]
16. Novel mutation c.1210-3C > G in cis with a poly-T tract of 5T affects CFTR mRNA splicing in a Chinese patient with cystic fibrosis.
Zhao X; Liu K; Xu W; Xiao M; Zhang Q; Song J; Chen K; Liu Y; Tian X; Xu KF; Zhang X
Front Med; 2022 Feb; 16(1):150-155. PubMed ID: 34302615
[TBL] [Abstract][Full Text] [Related]
17. A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis.
Mickle JE; Macek M; Fulmer-Smentek SB; Egan MM; Schwiebert E; Guggino W; Moss R; Cutting GR
Hum Mol Genet; 1998 Apr; 7(4):729-35. PubMed ID: 9499426
[TBL] [Abstract][Full Text] [Related]
18. A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR[delta]F508.
deCarvalho AC; Ndi CP; Tsopmo A; Tane P; Ayafor J; Connolly JD; Teem JL
Mol Med; 2002 Feb; 8(2):75-87. PubMed ID: 12080183
[TBL] [Abstract][Full Text] [Related]
19. A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo.
French PJ; van Doorninck JH; Peters RH; Verbeek E; Ameen NA; Marino CR; de Jonge HR; Bijman J; Scholte BJ
J Clin Invest; 1996 Sep; 98(6):1304-12. PubMed ID: 8823295
[TBL] [Abstract][Full Text] [Related]
20. Correction of a Cystic Fibrosis Splicing Mutation by Antisense Oligonucleotides.
Igreja S; Clarke LA; Botelho HM; Marques L; Amaral MD
Hum Mutat; 2016 Feb; 37(2):209-15. PubMed ID: 26553470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
